CP-383

N/A

Report date: 2025/06/26 20:00:07
NME

Base Information

Drug NameCP-383
Drug Alias NameCP-383
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsSolid tumoursUrinary Bladder NeoplasmsSmall Cell Lung Carcinoma +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesTasca Therapeutics Corp
China Registration ClassN/A

Develop Information

Active CompaniesTasca Therapeutics Inc
Inactive CompaniesTasca Therapeutics Corp
Active IndicationsSolid tumoursUrinary Bladder NeoplasmsSmall Cell Lung Carcinoma +[7] 
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A